We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PET Drugmakers Must File NDA, ANDA or IND by End of 2015
PET Drugmakers Must File NDA, ANDA or IND by End of 2015
January 2, 2013
All positron emission tomography (PET) producers must have an approved new drug application, abbreviated NDA or effective investigational new drug (IND) application by Dec. 12, 2015, according to an FDA guidance published in the Dec. 4 Federal Register.